VT
Insider buying
Vuong Trieu bought $10K of OTLC stock
Vuong Trieu, Chairman And CEO, 10% of Oncotelic Therapeutics, Inc. (OTLC), bought 240,000 shares of OTLC stock worth $10K, per an SEC Form 4 filed Jul 2, 2026.
It was an open-market purchase.
The trade happened on Jul 1, 2026, 1 day before it was made public.
- Traded
- Jul 1, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 1 day
- Role
- Chairman And CEO, 10%
- Source
- SEC Form 4
More OTLC insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.